Innate Pharma S.A. (IPHA) PT Raised to $16 at Citi
Tweet
Share
E-mailGet Alerts IPHA Hot Sheet
Price: $2.18 -14.17%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Innate Pharma S.A. (NASDAQ: IPHA) to $16.00 (from $14.00) while maintaining a Buy rating.
You May Also Be Interested In
- Innate Pharma S.A. (IPHA) PT Raised to $7 at H.C. Wainwright
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
- Leerink Upgrades Innate Pharma S.A. (IPHA) to Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
